Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments

By sjmartinez • November 18, 2022

Wang X, Liu X, Hugo W, Si L, Shi H. Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments. Front Immunol. 2022 Oct 31;13:1065937. doi: 10.3389/fimmu.2022.1065937. PMID: 36389823; PMCID: PMC9661360.

Tags: Biomarker, combination therapy, Dermatology, immune checkpoint blockade (ICB), immune checkpoint inhibitors (ICIs), immune-related adverse events (irAEs), melanoma, Publications

Trends in MD-PhD representation and match outcomes across competitive specialties, 2007-2024

Zhou AE, Klufas T, Choi E, Kim YW, Kim JJ, Sarfo A, Sloan B, Feng H. Trends in MD-PhD representation and match outcomes across competitive[...]

Ethical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology

Jonnalagadda A, Lowry WP, Pathak GN, Choi E, Zhou AE, Grant-Kels JM. Ethical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology. Clin Dermatol. 2026[...]

Epidermotropic Metastatic Prostate Adenocarcinoma With Florid Squamous Transformation/Differentiation and Associated Acantholysis. An Unusual Clinicopathologic Entity

Hoffman SJ, Sadrolashrafi K, Mobini N. Epidermotropic Metastatic Prostate Adenocarcinoma With Florid Squamous Transformation/Differentiation and Associated Acantholysis. An Unusual Clinicopathologic Entity. Case Rep Dermatol Med.[...]